FIELD: organic chemistry, chemistry of proteins, pharmacy. SUBSTANCE: invention describes novel peptides used for treatment of patients suffering with depression. Indicated novel peptides are modifications of tripeptide hormone MIF synthesized among them by transformation of residues with terminal amino- group, residues with terminal carboxyl group and internal amino acid residues including addition or substitution of amino acid residues and transformation of peptide bonds and functional side groups of corresponding amino acid residues. For treatment of patients suffering with depression tri-, tetra-, penta- and polypeptides can be used both separately and in the composition. EFFECT: new peptides indicated above, valuable medicinal properties. 107 cl, 3 dwg, 1 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
NEW COMPOSITIONS OF EXENDINE AGONISTS AND METHODS OF THEIR ADMINISTRATION | 2000 |
|
RU2242244C2 |
METHOD OF GLP-1 MOLECULES INTRODUCTION | 2003 |
|
RU2332229C2 |
METHOD FOR INHIBITING GLUCAGON | 2000 |
|
RU2247575C9 |
α-CYCLODEXTRIN-BASE PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION OF ANALOGS OF RELEASING-HORMONE OF LUTEINIZING HORMONE (LH-RH) | 1999 |
|
RU2214270C2 |
METHODS AND COMPOSITIONS FOR GASTROENTERIC UPSET THERAPY | 2004 |
|
RU2353383C2 |
METHODS AND COMPOSITIONS FOR TREATING GASTROINTESTINAL DISORDERS | 2004 |
|
RU2543350C2 |
COMPOSITIONS AND CORRESPONDING METHODS FOR AGRICULTURE | 2018 |
|
RU2783258C2 |
COMPOSITIONS AND CORRESPONDING METHODS FOR THE CONTROL OF DISEASES TRANSMITTED BY VECTORS | 2018 |
|
RU2804136C2 |
METHODS AND COMPOSITIONS FOR TREATMENT OF GASTROINTESTINAL DISORDERS | 2014 |
|
RU2763796C2 |
NEOANTIGENS AND THEIR USE | 2019 |
|
RU2813924C2 |
Authors
Dates
2002-05-27—Published
1995-05-02—Filed